Dental Care Clinics in Stevensville, MD Accepting Medicare
7 Dental Care Clinics found. Showing 1 - 7
 Kent Island Orthodontics Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 206 Duke St, Stevensville, MD 21666 Phone: 410-855-4430 |
Dudley Katz D.d.s.p.c. Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 101 Saint Claire Pl, Suite 102, Stevensville, MD 21666 Phone: 410-604-2222 |
Gregory Moffitt Dds Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 101 Saint Claire Pl Ste 102, Stevensville, MD 21666 Phone: 410-604-2222 |
Kent Island Pediatric Dentistry Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 160 Sallitt Dr, Suite 106, Stevensville, MD 21666 Phone: 410-604-2211 |
J.a.k. Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 352 Thompson Creek Mall, Stevensville, MD 21666 Phone: 410-934-0123 Fax: 410-934-0124 |
Bayside Dental Associates, Pa Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 208 Saint Claire Pl, Stevensville, MD 21666 Phone: 410-643-8110 Fax: 410-643-5311 |
Mid America Dental Group Of Maryland Pc Dentist Medicare: Not Enrolled in Medicare Practice Location: 210 Pier 1 Rd, Ste 201, Stevensville, MD 21666 Phone: 317-886-6639 Fax: 888-547-0377 |
News Archive
Buprenorphine implants could be effective option to treat adults with opioid dependence
While buprenorphine has long been used to treat adults with opioid dependence, its efficacy can be hindered by lack of adherence to daily, sublingual (beneath the tongue) doses of the medication.
Researchers see individual differences in brain activation depending on person's preferences or aversions to risk
Distinct regions of the human brain are activated when people are faced with ambiguous choices versus choices involving only risk, Duke University Medical Center researchers have discovered.
BioAlliance, Vestiq enter licensing agreement to commercialize Oravig in the US
BioAlliance Pharma SA, an innovative Company dedicated to the development of orphan oncology products and to supportive care products, announces the execution of the licensing agreement with Vestiq Pharmaceuticals to commercialize Oravig in the United States for the treatment of oropharyngeal candidiasis in adults.
Stryker adopts quarterly dividend payment policy
Stryker Corporation announced today that its Board of Directors has modified its dividend policy to adopt a quarterly payment schedule in lieu of an annual dividend. In conjunction with this modification, the Company's Board of Directors has declared a cash transition dividend of $0.10 per share, payable December 16, 2009, to shareholders of record at the close of business on November 18, 2009.
› Verified 7 days ago